Mid-term report 2016 – Cancer prevention and precision medicine

In connection with Stiftelsen Kristian Gerhard Jebsen's Mid-term evaluation of The K.G. Jebsen Colorectal Cancer Research Centre, we have issued a Mid-term report.

Mid-term report 2016

Link to the report Mid-term_report 2016_oppslag

Latest publications

Berg et al. 2020. Genomic and prognostic heterogeneity among RAS/BRAFV600E /TP53 co-mutated resectable colorectal liver metastases. Mol Oncol [Epub ahead of print] Flatin et al. 2020. Multiregional assessment of CIMP in primary colorectal cancers: phenotype concordance but marker variability. Int J Cancer [Epub ahead of print] Pilleron et al. 2020. Age disparities in stage-specific colon cancer survival across seven countries: an ICBP SURVMARK-2 population-based study. Int J Cancer [Epub ahead of print] Bergsland et al. 2020. Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer. ESMO Open 5(6): e001040 Smeby et al. 2020. Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity. EBioMedicine 59: 102923 All publications